Histidine-rich glycoprotein function in hepatocellular carcinoma depends on its N-glycosylation status, and it regulates cell proliferation by inhibiting Erk1/2 phosphorylation

Oncotarget
Qinle ZhangYinkun Liu

Abstract

Hepatocellular carcinoma (HCC) is the third most common cause of cancer mortality. Significantly downregulated histidine-rich glycoprotein (HRG) during the dynamic stages (WB, WB7, and WB11) of neoplastic transformation of WB F344 hepatic oval-like cells was screened out by iTRAQ labeling followed by 2DLC-ESI-MS/MS analysis. HRG expression was significantly lower in HCC tissues. HRG overexpression in Huh7 and MHCC-97H hepatoma cell lines led to decreased cell proliferation, colony-forming ability, and tumor growth, and increased cell apoptosis. HRG could inhibit cell proliferation via the FGF-Erk1/2 signaling pathway by reducing Erk1/2 phosphorylation. On the other hand, the functional expression of HRG was also dependent on the glycosylation status at its N-terminal, especially at the glycosylation site Asn 125. The glycosylation of HRG may play a key competitive role in the interaction between HRG and heparin sulfate for binding bFGF and activating the FGF receptor. These findings provide novel insights into the molecular mechanism of HRG in HCC.

References

Dec 1, 1993·Environmental Health Perspectives·S Sell
Jan 28, 2004·Cancer Research·Anna-Karin OlssonLena Claesson-Welsh
May 13, 2004·The Journal of Biological Chemistry·Allison L JonesChristopher R Parish
Nov 23, 2005·Cell Proliferation·M R Alison, M J Lovell
Jul 11, 2006·Journal of Gastroenterology and Hepatology·Xiong-Zhi Wu, Dan Chen
Aug 25, 2006·Nature Reviews. Cancer·Paraskevi A Farazi, Ronald A DePinho
Sep 9, 2006·Cell·Kazuaki Ohtsubo, Jamey D Marth
Aug 4, 2007·Gastroenterology·Tetsuhiro ChibaHideki Taniguchi
Mar 17, 2009·Biochimica Et Biophysica Acta·Takeshi OhtaSadao Wakabayashi
Jan 23, 2010·Nature Reviews. Cancer·Nicholas Turner, Richard Grose
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Apr 15, 2011·Journal of Hematology & Oncology·Yi-sheng WangCong-jian Xu
Aug 2, 2011·Seminars in Thrombosis and Hemostasis·Sadao Wakabayashi, Takehiko Koide
Feb 14, 2013·Nature Reviews. Molecular Cell Biology·Regina Goetz, Moosa Mohammadi
Apr 10, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Dalbir S SandhuLewis R Roberts

❮ Previous
Next ❯

Methods Mentioned

BETA
glycosylation
PCR
tissue array
Flow
flow cytometry

Software Mentioned

SPSS

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis